Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. According to the update, MZ Group will work closely with Trxade Group management in the development and implementation of a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. “This is an exciting time for Trxade Group, having achieved key growth milestones in 2019, positioning us for a breakout year in 2020 as we continue to scale our proprietary platform,” Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “The importance of our trading platform has been validated by the market, having grown our footprint of registered independent pharmacy members to 40% in 2019 to over 12,100 locations nationwide. These pharmacies have seen purchasing efficiencies on our platform before and during the COVID-19 pandemic, as we uniquely positioned to supply COVID-19 test kits in time to make a difference in the lives of their patients. Together with MZ Group, we will enhance our investor communications and awareness efforts, while simultaneously working to create sustainable value for our shareholders over the long-term.”

To view the full press release, visit

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same day or mail order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS). Bookmark the permalink.

Comments are closed.